Presentation Information

[F1-73]Reciprocal roles of interleukin-33 in a lipid nanoparticle mRNA vaccine-induced cytotoxic T cell and type 2 responses

*Kaiwen Liu1,2,3, Kouji Kobiyama1,2,3,8, Naoko Satoh-Takayama4, Tomoya Hayashi1,2,3, Burcu Temizoz1,2,3, Hideo Negishi1,2,3,5, Asuka Joy Tobuse1, Mai Onaga1, Peter D Katsikis6, Cevayir Coban2,3,7, Ken J Ishii1,2,3 (1. Division of Vaccine Science, IMSUT (Japan), 2. International Vaccine Design Center, IMSUT (Japan), 3. The UTOPIA Center, The University of Tokyo (Japan), 4. Precision Immune Regulation RIKEN ECL Research Unit, RIKEN Center for Integrative Medical Sciences (Japan), 5. Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, the University of Tokyo (Japan), 6. Department of Immunology, Erasmus University Medical Center (Netherlands), 7. Division of Malaria Immunology, the Institute of Medical Science, IMSUT (Japan), 8. Division of Rheumatology, Department of Medicine, University of California San Diego (USA))

Password required to view


Comment

To browse or post comments, you must log in.Log in